• 1. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 2. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 3. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 4. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 5. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143

Professional Introduction to trans-1,2-Bis-aminomethyl-cyclobutan (CAS No. 3396-16-5)

trans-1,2-Bis-aminomethyl-cyclobutan, identified by the Chemical Abstracts Service Number (CAS No.) 3396-16-5, is a significant compound in the field of chemical and pharmaceutical research. This bicyclic amine derivative has garnered attention due to its unique structural properties and potential applications in drug development and material science. The compound's molecular structure, featuring a cyclobutane ring substituted with two amino methyl groups, makes it a versatile intermediate for synthesizing complex molecules.

The< strong>trans-configuration of the amino groups contributes to the compound's distinct stereochemistry, which is crucial for its interaction with biological targets. This stereochemical arrangement can influence the compound's pharmacological activity, solubility, and metabolic stability. In recent years, there has been growing interest in exploring the< strong>1,2-bis-aminomethyl-cyclobutan scaffold for its potential in designing novel therapeutic agents.

Recent studies have highlighted the utility of< strong>trans-1,2-Bis-aminomethyl-cyclobutan in the synthesis of peptidomimetics and protease inhibitors. The cyclobutane ring provides a rigid framework that can mimic peptide bonds, while the amino methyl groups offer sites for further functionalization. This has led to its incorporation into libraries of compounds screened for biological activity. For instance, researchers have utilized this scaffold to develop inhibitors targeting enzymes involved in inflammatory pathways.

In addition to its pharmaceutical applications, CAS No. 3396-16-5 has shown promise in materials science. The unique properties of this compound make it suitable for developing advanced polymers and coatings with enhanced thermal stability and mechanical strength. The presence of multiple reactive sites allows for the creation of cross-linked networks, which can be tailored for specific industrial uses.

The synthesis of< strong>trans-1,2-Bis-aminomethyl-cyclobutan involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic techniques, such as transition metal catalysis and asymmetric synthesis, have been employed to achieve high yields and enantiopurity. These methods are essential for producing derivatives with specific stereochemical requirements for drug development.

One of the most compelling aspects of< strong>CAS No. 3396-16-5 is its role in medicinal chemistry as a building block for drug discovery. The compound's ability to undergo selective modifications allows chemists to explore a wide range of pharmacophores. Recent advancements in computational chemistry have further facilitated the design of derivatives with optimized pharmacokinetic properties. Virtual screening and molecular docking studies have been instrumental in identifying lead compounds based on this scaffold.

The< strong>1,2-bis-aminomethyl-cyclobutan moiety has also been investigated for its potential in creating metal-organic frameworks (MOFs). These materials are highly porous and can be tailored for applications such as gas storage, separation technologies, and catalysis. The amino groups provide coordination sites for metal ions, enabling the formation of stable and functional frameworks.

In conclusion, trans-1,2-Bis-aminomethyl-cyclobutan (CAS No. 3396-16-5) is a multifaceted compound with significant implications in both pharmaceuticals and materials science. Its unique structural features and reactivity make it a valuable tool for researchers seeking to develop novel therapeutics and advanced materials. As our understanding of its properties continues to grow, so too will its applications across various scientific disciplines.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)